Adam Mendelsohn, PhD

CHAIRMAN OF THE BOARD

Dr. Mendelsohn is the Chief Executive Officer and a director of Vivani, Cortigent’s parent company.  He founded Nano Precision Medical which became Vivani after acquiring Second Sight Medical Products (Cortigent’s predecessor) in 2022. Dr. Mendelsohn received his PhD in bioengineering at the UC San Francisco/UC Berkeley Joint Graduate Group in Bioengineering, was awarded an NSF fellowship to perform research at Kyoto University and has published multiple peer-reviewed articles describing new treatment options for Type 1 diabetes. Dr. Mendelsohn has served as a Technical Advisor to the Alfred E. Mann Institute for Biomedical Engineering at USC, a fellow of the Startup Leadership Program, and is currently a board member of the Maestro Foundation. Dr. Mendelsohn completed his certificate in Management of Technology with the Haas School of Business.